Yi Zhong David Qi
Vorstandsvorsitzender bei Sino European Biotechnology AG
Ursprung des Netzwerks ersten Grades von Yi Zhong David Qi
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Sino European Biotechnology AG
Sino European Biotechnology AG Medical SpecialtiesHealth Technology Sino European Biotechnology AG develops virus vaccines. Its products include Insulidow capsules to treat diabetes, Prostaidin for prostate disease-specific, Osteogird for bone diseases, Keanbo, the anti-tumour and immune capsules and RYR capsules to treat cholesterol, triglycerides and blood viscosity lipids. The company is headquartered in Zurich, Switzerland.
4
| Private Company | Medical Specialties | 4 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Yi Zhong David Qi
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
The Chinese Medical Association | Corporate Officer/Principal | ||
Zhejiang Chinagene Biomedical Co. Ltd.
Zhejiang Chinagene Biomedical Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of Sino European Biotechnology AG, Zhejiang Chinagene Biomedical Co. Ltd. is a Chinese pharmaceutical company that manufactures pharmaceutical products. The company is based in Hangzhou, China. Zhejiang Chinagene Biomedical Co. was acquired by Sino European Biotechnology AG on March 31, 2010. | Pharmaceuticals: Major | Director/Board Member |
Statistik
International
China | 3 |
Sektoral
Health Technology | 2 |
Operativ
Director/Board Member | 5 |
Corporate Officer/Principal | 1 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
Yao Zhou Zhang | 2 |
Zi Hao Liang | 2 |
Yong Shen Fang | 1 |
Li Ping Tang | 1 |
- Börse
- Insiders
- Yi Zhong David Qi
- Unternehmensverbindungen